腹腔镜手术治疗肝内胆管细胞癌研究现状  

Current situation and future prospect of laparoscopic treatment of intrahepatic cholangiocarcinoma

作　　者：盛宇斌 梁霄[2] SHENG Yu-bin;LIANG Xiao(Shaoxing University School of Medicine,Shaoxing 312000,China;不详)

机构地区：[1]绍兴文理学院医学院,浙江绍兴312000 [2]浙江大学医学院附属邵逸夫医院普外科,浙江杭州310000

出　　处：《中国实用外科杂志》2022年第7期833-835,共3页Chinese Journal of Practical Surgery

基　　金：浙江省重点研发计划(No.2021C03127);国家自然科学基金(No.82072625);浙江省医药卫生科技计划省部共建重点项目(No.WKJ-ZJ-2030)。

摘　　要：肝内胆管细胞癌(ICC)是仅次于肝细胞癌的第二大原发性肝癌,发病率逐年上升,手术是唯一可能治愈ICC的方法。但由于ICC的生物学特性,腹腔镜肝切除术治疗ICC在操作规范和疗效上仍存在争议。对于ICC病人,腹腔镜肝切除术中实施淋巴结清扫安全可行,与开放手术相比,腹腔镜肝切除术具有术中出血量少、术后并发症发生率低、术后住院时间短等优势,并未增加病人围术期病死率,但在远期疗效上暂未体现优势。Intrahepatic cholangiocarcinoma(ICC) is the second largest primary liver cancer only compared with hepatocellular carcinoma. The incidence rate is increasing year by year. Surgery is the only possible way to cure ICC.However, in view of the biological characteristics of ICC,laparoscopic hepatectomy(LLR)for the treatment of ICC is still controversial. It is feasible to perform lymph node dissection under the laparoscopic treatment of ICC. LLR treatment of ICC,compared with traditional open surgery(OLR),has clear advantages such as less intraoperative bleeding,fewer postoperative minor complications,shorter hospital stay,and does not increase the perioperative mortality of patients. LLR treatment of ICC has no significant advantage in the long-term efficacy.

关 键 词：肝内胆管细胞癌 腹腔镜肝切除术 微创手术 开放肝切除术 争议 

分 类 号：R6[医药卫生—外科学]